JY
AGL icon

Jeff Yass’s Agilon Health AGL Stock Holding History

Jeff Yass’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Buy
140,600
+122,200
+664% +$8M ﹤0.01% 2792
2026
Q1 		$146K Buy
18,400
+17,656
+2,373% +$285K ﹤0.01% 12039
2025
Q4 		$12.8K Sell
744
-1,212
-62% -$23.5K ﹤0.01% 12031
2025
Q3 		$50.4K Sell
1,956
-272
-12% -$10.3K ﹤0.01% 11858
2025
Q2 		$128K Sell
2,228
-11,184
-83% -$897K ﹤0.01% 11620
2025
Q1 		$1.45M Sell
13,412
-1,344
-9% -$117K ﹤0.01% 6293
2024
Q4 		$701K Buy
14,756
+3,596
+32% +$217K ﹤0.01% 7823
2024
Q3 		$1.1M Sell
11,160
-4,316
-28% -$557K ﹤0.01% 6578
2024
Q2 		$2.53M Buy
15,476
+5,792
+60% +$825K ﹤0.01% 4626
2024
Q1 		$1.48M Buy
9,684
+4,804
+98% +$799K ﹤0.01% 6040
2023
Q4 		$1.53M Sell
4,880
-3,692
-43% -$1.34M ﹤0.01% 5957
2023
Q3 		$3.81M Buy
8,572
+1,996
+30% +$902K ﹤0.01% 3994
2023
Q2 		$2.85M Sell
6,576
-36
-0.5% -$20.2K ﹤0.01% 4453
2023
Q1 		$3.93M Buy
6,612
+5,960
+914% +$3.34M ﹤0.01% 3825
2022
Q4 		$263K Sell
652
-3,500
-84% -$1.64M ﹤0.01% 9421
2022
Q3 		$2.43M Sell
4,152
-804
-16% -$481K ﹤0.01% 4532
2022
Q2 		$2.71M Buy
4,956
+4,512
+1,016% +$2.28M ﹤0.01% 4267
2022
Q1 		$281K Sell
444
-344
-44% -$177K ﹤0.01% 10419
2021
Q4 		$532K Sell
788
-912
-54% -$555K ﹤0.01% 9020
2021
Q3 		$1.11M Buy
1,700
+1,228
+260% +$1.05M ﹤0.01% 7275
2021
Q2 		$479K Buy
+472
New +$413K ﹤0.01% 9701

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jeff Yass's AGL Position: Q2 2026 in Review

Jeff Yass reduced its Agilon Health (AGL) stake by 60% in Q2 2026, selling an estimated $457K and leaving 4,600 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #9955.

Jeff Yass first reported a position in AGL in Q2 2021 and has held it in 18 quarters since. The position peaked at $3.57M in Q1 2024. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Jeff Yass held 4,600 shares of Agilon Health worth $493K as of Q2 2026.
  • Jeff Yass sold 6,970 Agilon Health shares in Q2 2026, an estimated $457K.
  • Agilon Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9955 holding.
  • Jeff Yass first reported a position in Agilon Health in Q2 2021 and has held it in 18 quarters since.
  • Jeff Yass's Agilon Health position peaked at $3.57M in Q1 2024.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.